Latest filing published 06 Mar 2024 for Adaptive Biotechnologies Corp.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Tycho Peterson: trading record in brief
This profile gathers the share dealings of Tycho Peterson in Adaptive Biotechnologies Corp, where the filings describe the role as finance chief. We count 11 filings; the first trade dates from 1 June 2022 and the latest from 5 March 2024.
No open-market purchase appears, only 6 sales worth €1.9M. Besides market trades, the filings include 3 share grants and 2 option exercises. In 2024 alone, the filings show no purchases and 1 sale.
The record was last updated on 6 March 2024 with a share grant in Adaptive Biotechnologies Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Tycho Peterson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 147,790 shares0Common StockSEC:0001062993-24-005759:0
- 134,961 shares@ US$7.3056.8% of flowCommon StockSEC:0001062993-23-013930:0
- 55,672 shares@ US$8.5327.3% of flowCommon StockSEC:0001062993-23-013872:0
- 38,000 shares@ US$7.1615.9% of flowCommon StockSEC:0001062993-23-013030:0
- 118,203 shares0Common StockSEC:0001062993-23-006326:0
- 374,688 shares0Common StockSEC:0001209191-22-034343:0
6 of 6 declarations
